レポートナンバー 0000029499
日光角化症治療薬の世界市場（2021-2025）
TechNavio
Global Actinic Keratosis Drugs Market 2021-2025
発刊日
2021/04/21
言語英語
体裁PDF/120ページ
レポート概要
本レポートは、世界の日光角化症治療薬市場を分析します。
世界の日光角化症治療薬市場は、予測期間中に約4%のCAGRで推移し、2021年から2025年の間に7億982万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。同市場は、日光角化症の高い有病率と、致命的な病気に転換する脅威によって促進されています。さらに、日光角化症の高い有病率は、市場の成長も後押しすると予想されます。
調査範囲
-
市場セグメント
➣ 製品別
◇ ヌクレオシド代謝阻害薬
◇ 免疫調節剤薬
◇ 光増感剤薬
◇ NSAID（非ステロイド系抗炎症薬）
➣ 地域別
◇ 北アメリカ
◇ アジア太平洋地域（APAC）
◇ ヨーロッパ
◇ その他の地域
この調査は、今後数年間の日光角化症治療薬市場の成長を推進する主な理由の1つとして、併用療法の利用可能性を特定しています。
Technavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。
本レポートは以下の分野をカバーしています。
- 日光角化症治療薬の市場規模
- 日光角化症治療薬の市場予測
- 日光角化症治療薬市場の業界分析
Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な日光角化症治療薬市場ベンダーの詳細な分析を提供します
調査企業
- 3M Co.
- Almirall SA
- Bausch Health Companies Inc.
- Biofrontera AG
- Cipher Pharmaceuticals Inc.
- Hill Dermaceuticals Inc.
- Mylan NV
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vidac Pharma
また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
Technavio社について
Technavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
レポート詳細
目次
Table of Contents
Executive Summary
Market Overview
Market Landscape
Market ecosystem
Market characteristics
Value chain analysis
Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by Product
Market segments
Comparison by Product
Nucleoside metabolic inhibitors - Market size and forecast 2020-2025
Immunomodulators - Market size and forecast 2020-2025
Photosensitizers - Market size and forecast 2020-2025
NSAIDs - Market size and forecast 2020-2025
Market opportunity by Product
Customer landscape
Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
APAC - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends
Vendor Landscape
Overview
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
3M Co.
Almirall SA
Bausch Health Companies Inc.
Biofrontera AG
Cipher Pharmaceuticals Inc.
Hill Dermaceuticals Inc.
Mylan NV
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Vidac Pharma
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
Exhibits
Exhibits1: Key Finding
Exhibits2: Key Finding
Exhibits3: Key Finding
Exhibits4: Key Finding
Exhibits5: Key Finding
Exhibits6: Key Finding
Exhibits7: Key Finding
Exhibits8: Parent market
Exhibits9: Market characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits14: Five forces analysis 2020 & 2025
Exhibits15: Bargaining power of buyers
Exhibits16: Bargaining power of suppliers
Exhibits17: Threat of new entrants
Exhibits18: Threat of substitutes
Exhibits19: Threat of rivalry
Exhibits20: Market condition - Five forces 2020
Exhibits21: Product - Market share 2020-2025 (%)
Exhibits22: Comparison by Product
Exhibits23: Nucleoside metabolic inhibitors - Market size and forecast 2020-2025 ($ million)
Exhibits24: Nucleoside metabolic inhibitors - Year-over-year growth 2020-2025 (%)
Exhibits25: Immunomodulators - Market size and forecast 2020-2025 ($ million)
Exhibits26: Immunomodulators - Year-over-year growth 2020-2025 (%)
Exhibits27: Photosensitizers - Market size and forecast 2020-2025 ($ million)
Exhibits28: Photosensitizers - Year-over-year growth 2020-2025 (%)
Exhibits29: NSAIDs - Market size and forecast 2020-2025 ($ million)
Exhibits30: NSAIDs - Year-over-year growth 2020-2025 (%)
Exhibits31: Market opportunity by Product
Exhibits32: Customer landscape
Exhibits33: Market share by geography 2020-2025 (%)
Exhibits34: Geographic comparison
Exhibits35: North America - Market size and forecast 2020-2025 ($ million)
Exhibits36: North America - Year-over-year growth 2020-2025 (%)
Exhibits37: APAC - Market size and forecast 2020-2025 ($ million)
Exhibits38: APAC - Year-over-year growth 2020-2025 (%)
Exhibits39: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits40: Europe - Year-over-year growth 2020-2025 (%)
Exhibits41: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits42: ROW - Year-over-year growth 2020-2025 (%)
Exhibits43: Key leading countries
Exhibits44: Market opportunity by geography ($ million)
Exhibits45: Impact of drivers and challenges
Exhibits46: Vendor landscape
Exhibits47: Landscape disruption
Exhibits48: Industry risks
Exhibits49: Vendors covered
Exhibits50: Market positioning of vendors
Exhibits51: 3M Co. - Overview
Exhibits52: 3M Co. - Business segments
Exhibits53: 3M Co. - Key offerings
Exhibits54: 3M Co. - Key customers
Exhibits55: 3M Co. - Segment focus
Exhibits56: Almirall SA - Overview
Exhibits57: Almirall SA - Product and service
Exhibits58: Almirall SA - Key offerings
Exhibits59: Almirall SA - Key customers
Exhibits60: Almirall SA - Segment focus
Exhibits61: Bausch Health Companies Inc. - Overview
Exhibits62: Bausch Health Companies Inc. - Business segments
Exhibits63: Bausch Health Companies Inc. - Key offerings
Exhibits64: Bausch Health Companies Inc. - Key customers
Exhibits65: Bausch Health Companies Inc. - Segment focus
Exhibits66: Biofrontera AG - Overview
Exhibits67: Biofrontera AG - Product and service
Exhibits68: Biofrontera AG - Key offerings
Exhibits69: Biofrontera AG - Key customers
Exhibits70: Biofrontera AG - Segment focus
Exhibits71: Cipher Pharmaceuticals Inc. - Overview
Exhibits72: Cipher Pharmaceuticals Inc. - Business segments
Exhibits73: Cipher Pharmaceuticals Inc. - Key offerings
Exhibits74: Cipher Pharmaceuticals Inc. - Key customers
Exhibits75: Cipher Pharmaceuticals Inc. - Segment focus
Exhibits76: Hill Dermaceuticals Inc. - Overview
Exhibits77: Hill Dermaceuticals Inc. - Product and service
Exhibits78: Hill Dermaceuticals Inc. - Key offerings
Exhibits79: Hill Dermaceuticals Inc. - Key customers
Exhibits80: Hill Dermaceuticals Inc. - Segment focus
Exhibits81: Mylan NV - Overview
Exhibits82: Mylan NV - Business segments
Exhibits83: Mylan NV - Key offerings
Exhibits84: Mylan NV - Key customers
Exhibits85: Mylan NV - Segment focus
Exhibits86: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits87: Sun Pharmaceutical Industries Ltd. - Business segments
Exhibits88: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits89: Sun Pharmaceutical Industries Ltd. - Key customers
Exhibits90: Sun Pharmaceutical Industries Ltd. - Segment focus
Exhibits91: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits92: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits93: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits94: Teva Pharmaceutical Industries Ltd. - Key customers
Exhibits95: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits96: Vidac Pharma - Overview
Exhibits97: Vidac Pharma - Business segments
Exhibits98: Vidac Pharma - Key offerings
Exhibits99: Vidac Pharma - Key customers
Exhibits100: Vidac Pharma - Segment focus
Exhibits101: Currency conversion rates for US$
Exhibits102: Research Methodology
Exhibits103: Validation techniques employed for market sizing
Exhibits104: Information sources
Exhibits105: List of abbreviations
